Carbon monoxide may help explain the long-observed but perplexing association between smoking and a lower risk for ...

Novo Nordisk’s phase 3b trial shows once-weekly IcoSema improves glycemic control and weight with less hypoglycemia than insulin glargine U100 in adults with type 2 diabetes.

The walkouts are the next stage of the doctors’ effort to improve what they call long hours and poor working conditions.

Some doctors are trading crammed itineraries for something radical on vacation: doing absolutely nothing at all.

Pharmacogenetic testing can inform medication choice and adverse effect risk, while questions remain about implementation, data storage, and access in routine care.

Daily use of an oral probiotic from 6 to 24 months of age may not reduce the occurrence of ear or respiratory tract infections and antibiotic use in healthy infants.